Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced ...

Imvax, Inc. today announced an oral presentation and two poster presentations at the 2024 SNO Annual Meeting in Houston, Texas.

TEXILA American University held its Pinktober event on October 25, 2024, at its Providence, East Bank Demerara location which ...

The 7th edition of the Apollo Cancer Conclave, being organized by Apollo Cancer Centers, Mumbai began and is being attended by over 2,000 Oncologists with over 400 faculty from leading national and in ...

Company to share preclinical data across diverse pipeline of iNK, γδ iT, and αβ iT cell therapy programs for oncology and autoimmune disease ...

Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...

Clinical research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) continues to ...

Live webcasts of the presentations and any accompanying materials will be available under the News & Events section of Olema's investor relations website at ir.olema.com. The webcasts will be archived ...

About NX-5948: NX-5948 is an investigational, orally bioavailable degrader of BTK that is currently being evaluated in a ...

The list of presentations at ASHG, which was held in Denver, CO, included one from healthcare company PrognomiQ focused on ...